- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/16 - Purine radicals
Patent holdings for IPC class C07H 19/16
Total number of patents in this class: 776
10-year publication summary
|
73
|
60
|
61
|
67
|
71
|
50
|
54
|
40
|
30
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Atea Pharmaceuticals, Inc. | 75 |
25 |
| Illumina Cambridge Limited | 670 |
22 |
| Gilead Sciences, Inc. | 2060 |
15 |
| Epizyme, Inc. | 374 |
14 |
| The Trustees of Columbia University in the City of New York | 3592 |
13 |
| Janssen Biopharma, Inc. | 40 |
13 |
| Idenix Pharmaceuticals LLC | 62 |
12 |
| Osaka University | 3394 |
12 |
| Centre National de La Recherche Scientifique | 10576 |
11 |
| Dana-Farber Cancer Institute, Inc. | 2600 |
11 |
| Emory University | 1641 |
11 |
| The Scripps Research Institute | 1347 |
11 |
| Roche Innovation Center Copenhagen A/S | 135 |
10 |
| Merck Sharp & Dohme Corp. | 2190 |
9 |
| Arcus Biosciences, Inc. | 140 |
9 |
| Janssen Pharmaceuticals, Inc. | 437 |
8 |
| Idenix Pharmaceuticals, Inc. | 45 |
8 |
| Ionis Pharmaceuticals, Inc. | 890 |
8 |
| The Regents of the University of California | 20137 |
7 |
| Janssen Pharmaceutica N.V. | 3370 |
7 |
| Other owners | 540 |